2 - Neutrophils pt. 2 Flashcards

1
Q

What is swarming?

A
  • collective behaviour exhibited by cells, clime mounds, insects
  • relies on positive feedback loops and self regulatory mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What was found about swarming in 2008?

A

Noted 2008 for neutrophils in mouse lymph nodes infected with protozoan parasites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Advances in swarming

A
  • Since then, advances in cell imaging have enabled detailed characterization of swarms and their regulation, although control of resolution still largely unknown.
  • ‘Pioneer’ neutrophils (NTs) react to stimulus and form small clusters, followed by large (several hundred) migration of other NTs. Swarms compete for NT recruitment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How can neutrophil swarm phenotypes be catergorised?

A

Neutrophil-swarm phenotypes can be broadly categorized into two forms: transient and persistent swarms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Transient swarms

A
  • Transient neutrophil swarms form small cell clusters for few minutes before quickly dispersing again
  • Neutrophils perform chemotactic migration toward a neutrophil accumulation and migrate out again to join nearby growing swarm centres
  • Individual neutrophils often move between competing swarms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Persistent swarms

A

Persistent swarms show a sustained neutrophil recruitment and form large-cell clusters that can remain stable and persist for hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are transient swarms found?

A
  • lymph nodes
  • lungs
  • intestines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are persistent swarms found?

A
  • skin
  • liver
  • spleen
  • cornea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What did Kienle find about swarms (2021)?

A
  • NTs secrete attractants, which act through cell surface-expressed G protein-coupled receptors (GPCRs) on adjacent cells
  • high chemoattractant concentrations (positive feedback loop) lead to GPCR desensitisation at later stages of the swarm, mediated by GPCR kinases (esp. GRK2)
  • desensitisation leads to optimal bacterial detection and containment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Killing mechanisms:

A
  1. phagocytosis - pathogens frequently opsonised e.g., by Ab or complement factors
  2. degranulation - extracellular release of anti-microbial molecules
  3. NETs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens after the killing mechanisms?

A
  • Neutrophils cleared by apoptosis in liver, spleen or bone marrow
  • Terminal trafficking – gut, to regulate commensals
  • Reverse trafficking – migrate away from site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Reverse trafficking: possible mechanisms (in vitro cell culture)

A

a. chemoattractants act as chemorepellent at high concentrations
b. reverse transmigration through endothelial cell layers
c. reverse migration in microfluidic chambers depends on which signals a neutrophil encounters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reverse trafficking: possible mechanisms (in vitro cell culture) described

A

a. Reverse neutrophil transmigration through endothelial cell monolayers has been reported; reverse transmigrated neutrophils have been characterised by high expression of intercellular adhesion molecule 1 (ICAM1) and low expression of CXC-chemokine receptor 1 (CXCR1)

b. In vitro analysis in microfluidics has identified factors that regulate neutrophil forward and reverse migration

c. The pro-resolving lipid mediator lipoxin A4 (LX4A) induces neutrophil reverse migration whereas zymosan induces neutrophil trapping.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can neutrophil migration be a drug target?

A
  • Failure to appropriately resolve inflammation - contributes to several inflammatory diseases, e.g. rheumatoid arthritis, pulmonary fibrosis, multiple organ failure
  • Neutrophil behaviour - potential target for drug therapies
  • Targeting forward migration: inhibit primary signals for neutrophil recruitment or amplification
  • Targeting reverse migration: promote neutrophil reverse migration from local sites of damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of drugs in current clinical trials that specifically target neutrophil migration signals

A
  1. SCH 527123 targets CXCR2 - severe asthma, allergen induced asthma, COPD, psoriasis, and colon cancer
  2. Reparixin targets CXCR1 and CXCR2 - ischaemia-reperfusion injury, lung, pancreatic islet and kidney transplantation, and beast cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are neutrophils classed as?

A

neutrophils are classed as ‘terminally differentiated’ cells

17
Q

Can neutrophils transform?

A

No capacity to transform into other cell types

18
Q

What are neutrophil subsets?

A

Now known that neutrophil subsets exist which show different phenotypes and functionality, and which can be characterized by expression of receptors/markers

19
Q

Examples of different neutrophil phenotypes

A

Tumour-associated neutrophils: N1 (anti-tumorigenic and pro-inflammatory) and N2 (pro-tumourigenic and immunosuppressive)

20
Q

Variations in neutrophil cell surface receptor expression include

A

-CXCR4 expression in aged/senescent neutrophils
-CD63 expression in the airways of cystic fibrosis patients
-Intercellular adhesion molecule 1 (ICAM1) expression associated with systemic inflammation and reverse migration

21
Q

What has research suggested about neutrophils and B cells?

A
  • Research has suggested neutrophils enhance B cell function and that this results from neutrophils being ‘reprogrammed’ by spleen endothelial cells
  • Originally thought that neutrophils only occupy the spleen during bacterial infection, observations suggested that there was natural colonization in the spleen marginal zone
22
Q

What has been proposed about neutrophils and B cells?

A

Proposed that interleukin 10 released from spleen cells ‘re-programmed’ neutrophils, which subsequently activated B cells and induced functions such as Ab production
- Defined existence of a neutrophil B helper cell sub-type, possessing a distinct phenotype (observable properties of a cell/organism)

Puga et al 2011

23
Q

Model of reprogramming proposed:

A

T cell-independent responses by human MZ B cells

  1. T cell-independent (Tl) antigens are thought to enter the marginal zone (MZ) through the perifollicular zone
  2. Once in the MZ, they may be captured by neutrophil extracellular trap (NET)-like structures emanating from B cell-helper neutrophils (NBH cells)
  3. These cells may differentiate from circulating neutrophils as a result of the production of interleukin-10 (IL-10) by perifollicular sinus-lining cells and macrophages in response to microbial Toll-like receptor (TLR) ligands
  4. Antigen capture may also involve reticular cells, macrophages, sinus-lining cells and dendritic cells (DCs)
  5. In addition to making Tl antigens available to the B cell receptor (BCR) and TLRs on MZ B cells, antigen-capturing cells release B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL), which engage transmembrane activator and CAML interactor (TACI) on MZ B cells. NBH cells also release IL-21, thereby inducing class-switch recombination, somatic hypermutation and antibody production in MZ B cells
  6. The generation of plasmablasts secreting IgM or class-switched IgG and IgA involves the production of IL-6, IL-10, IL-21 and CXC-chemokine ligand 10 (CXCL10) by antigen-capturing cells.

FIGURE: Arrows indicate the putative path followed by antigens through the spleen. IFN, interferon; PALS, periarteriolar lymphoid sheath; PRR, pattern-recognition receptor

24
Q

Was the proposed model successful?

A

“Failure to Detect Functional Neutrophil B Helper Cells in the Human Spleen” Nagelkerke et al.

25
Q

Main points of the lack of neutrophil B helper cells in the spleen paper

A
  • Homogenous population of neutrophils detected in fresh human spleen samples, which did not differ in phenotype/function from blood neutrophils
  • No phenotypic characteristics of costimulatory nature detected on neutrophils
  • No reproduction of Ig production by splenic B cells in the presence
  • of splenic neutrophils detected
  • B cell function and neutrophil activity were normal
  • Independent confirmation of a role for NBH cells is required.
26
Q

Possible reasons for the failure to detect function neutrophil B helper cells

A
  • Protocol differences for spleen cell collection and isolation
  • Cell contamination – B cells consistently contaminated neutrophil cultures
  • Neutrophils help by secreting cytokines, but may not have a different
    phenotype?
27
Q

Can metabolic changes alter neutrophil production, phenotype and function?

A
  • Studies in mice suggestion diurnal changes in neutrophil phenotypes
  • Conditions such as hyperglycaemia or hypercholesterolaemia now
    believed to influence increased production of reactive oxygen species (ROS) from neutrophils
  • ROS essential for killing
    -BUT Increased ROS linked to chronic inflammation
28
Q

Neutrophil phenotypes and disease

A

Different NT phenotypes now identified and associated with conditions
including: gum disease, asthma, cancer, survival from trauma

29
Q

Neutrophil phenotypes and COVID?

A

Different NT phenotypes recently linked with Covid severity, via examination of Covid patients and proteomic analysis of > 1700 NT proteins
- immunomodulatory receptors: significant differences in abundance in NT proteome
- migratory receptors/integrins: exclusively reduced abundance

30
Q

What does neutrophil swarming involve?

A

Neutrophil swarming involves positive feedback loop for aggregation
and desensitization to limit swarms

31
Q

What do killing mechanisms include?

A

Killing mechanisms include phagocytosis, degranulation and
extracellular trap formation

32
Q

What do killing mechanisms include?

A

Killing mechanisms include phagocytosis, degranulation and
extracellular trap formation

33
Q

Why is neutrophil life span/migration important?

A

Neutrophil life span/migration important in balance between acute and
chronic inflammation. Manipulation of migration of interest in drug
development

34
Q

Do neutrophil phenotypes exist?

A

Neutrophil phenotypes exist, including reports of new ‘helper’ neutrophil sub-type in spleen and associations with many different pathologies

35
Q

Why is ROS important?

A

Some phenotypes produce excess ROS: ROS needed for killing microbes, excess linked to numerous health conditions

36
Q

What has neutrophils recently been linked to?

A

Recent report links NT phenotype to Covid outcomes

37
Q

How does extravasation occur?

A

by paracellular or trans cellular routes

38
Q

Phenotypes of neutrophils

A

Neutrophils possess different phenotypes that have been linked to
factors such as aging and disease conditions, as well as claims that
distinct sets of ‘B helper’ neutrophils exist